Skip to main content
. 2020 Jul 21;11(9):2561–2569. doi: 10.1111/1759-7714.13574

Table 2.

Regimens of platinum‐based chemotherapy (n = 23)

Regimen DLL3‐positive (n = 12) DLL3‐negative (n = 11)
CDDP‐CPT‐11 8 5
CDDP + VP16 3 2
CDDP + VNR 0 1
CBDCA + VP16 0 1
CBDCA + PTX 1 2

CBDCA, carboplatin; CDDP, cisplatin; CPT‐11, irinotecan; PTX, paclitaxel; VP16, etoposide; VNR, vinorelbine.